Aimei Health Technology (NASDAQ:AFJK) Releases Earnings Results

Aimei Health Technology (NASDAQ:AFJK – Get Free Report) posted its quarterly earnings results on Monday. The company reported ($0.01) earnings per share for the quarter, FiscalAI reports.

Aimei Health Technology Stock Performance

AFJK traded down $0.56 on Monday, hitting $11.84. 961 shares of the company were exchanged, compared to its average volume of 19,672. The business’s fifty day moving average is $12.25 and its 200 day moving average is $25.96. Aimei Health Technology has a fifty-two week low of $6.75 and a fifty-two week high of $130.37. The firm has a market capitalization of $37.47 million, a P/E ratio of 197.28 and a beta of 0.97.

Institutional Inflows and Outflows

A hedge fund recently bought a new position in Aimei Health Technology stock. First Trust Capital Management L.P. purchased a new position in shares of Aimei Health Technology Co., Ltd. (NASDAQ:AFJK – Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 677,008 shares of the company’s stock, valued at approximately $8,199,000. First Trust Capital Management L.P. owned approximately 21.38% of Aimei Health Technology at the end of the most recent reporting period. 45.58% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms have issued reports on AFJK. Wall Street Zen upgraded Aimei Health Technology to a “sell” rating in a research report on Saturday, September 19th. Weiss Ratings downgraded Aimei Health Technology from a “sell (d+)” rating to a “sell (d)” rating in a report on Friday, August 21st. One equities research analyst has rated the stock with a Sell rating. Based on data from MarketBeat, the stock has an average rating of “Sell”.

Read Our Latest Stock Report on Aimei Health Technology

Aimei Health Technology Company Profile

(Get Free Report)

Aimei Health Technology Co., Ltd. is a special purpose acquisition company, or SPAC, formed to pursue a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company has stated that it intends to focus on opportunities in the healthcare and health technology sectors, including businesses with operations in China. It has not established an operating business of its own and is seeking a company to combine with.

Read More

Earnings History for Aimei Health Technology (NASDAQ:AFJK)

Receive News & Ratings for Aimei Health Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aimei Health Technology and related companies with MarketBeat.com's FREE daily email newsletter.